Vinergy Resources/MJ BioPharma Appoints Mr. Facundo Bacardi to Board of Directors

Mr. Bacardi is a member of the family that owns and controls Bacardi Ltd., a worldwide liquor manufacturer and distributor. From 1979 to 1991, he was the head of Bacardi’s manufacturing and distribution division for Nassau, Brazil, Trinidad and Central America. Since 1990, Mr. Bacardi has served as a Director of Suramericana de Inversiones, S.A., an investment company located in Panama. He is a founding shareholder of JSM Capital Holding Corp., a shareholder and Director of Global Arena Holdings, Inc. Mr. Bacardi is also on the Honorary Consul for the Bahamas in Panama.

“We are excited to have someone of Mr. Bacardi’s calibre and pedigree join our team. We look forward to working closely with him on our strategy to roll out products and technologies internationally,” said Mr. Kent Deuters, CEO of MJ Biopharma.

Mr. Bacardi, said: “I am happy to be joining the team at Vinergy and helping them move the business forward in the cannabis industry. Given my life-long experience in the spirits industry I see several areas in which I can add immediate value for the Company.”

Mr. Bacardi has been granted 100,000 options priced at $0.60, subject to CSE approval.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Vinergy Resources Ltd.

Glen Macdonald, Director

Cautionary Statement Regarding “Forward-Looking” Information

The forward-looking information contained in this press release is made as of the date of this press release and, except as required by applicable law, the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking information, whether as a result of new information, future events or otherwise, except as may be required by law. By its very nature, such forward-looking information requires the Company to make assumptions that may not materialize or that may not be accurate. This forward-looking information is subject to known and unknown risks and uncertainties and other factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied by such information.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$UTRM Announces Board Approval

United Treatment Centers, Inc. Announces Board Approval United Treatment Centers, Inc. Announces…

$CARA Initiates Phase 2 Trial of Oral CR845 in Osteoarthritis

Cara Therapeutics Initiates Phase 2 Trial of Oral CR845 in Osteoarthritis Trial…